In Re: 21st Century Oncology Holdings, Inc.

965 F.3d 196
CourtCourt of Appeals for the Second Circuit
DecidedJuly 20, 2020
Docket19-1725
StatusPublished

This text of 965 F.3d 196 (In Re: 21st Century Oncology Holdings, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re: 21st Century Oncology Holdings, Inc., 965 F.3d 196 (2d Cir. 2020).

Opinion

19-1725 In Re: 21st Century Oncology Holdings, Inc.

United States Court of Appeals for the Second Circuit

AUGUST TERM 2019 No. 19-1725

In Re: 21st Century Oncology Holdings, Inc., AKA Radiation Therapy Services Holdings, Inc., Reorganized Debtor.

************************************

ANDREW L. WOODS, Appellant,

v.

21ST CENTURY ONCOLOGY HOLDINGS, INC., AKA RADIATION THERAPY SERVICES HOLDINGS, INC., Reorganized Debtor-Appellee. *

ARGUED: MARCH 25, 2020 DECIDED: JULY 20, 2020

Before: JACOBS, POOLER, and CARNEY, Circuit Judges.

*The Clerk of the Court is respectfully directed to amend the official caption to conform to the above.

1 Andrew L. Woods appeals from a bankruptcy court order capping his

claim for certain incentive payments promised by his former employer pursuant

to 11 U.S.C. § 502(b)(7), which limits employee claims for damages “resulting

from the termination of an employment contract.” Because Woods’ right to

receive the payments was accelerated as a result of his termination, we hold that

§ 502(b)(7) applied to his claim, and therefore affirm the judgment of the

bankruptcy court.

Affirmed.

____________________

LEON N. PATRICIOS, Zumpano Patricios, P.A., Coral Gables, FL, (John E. Jureller, Jr., Klestadt Winters Jureller Southard & Stevens, LLP, on the brief) for Appellant Andrew L. Woods.

JEFFREY R. GLEIT, Sullivan & Worcester LLP, New York, NY, for Appellee 21st Century Oncology Holdings, Inc., AKA Radiation Therapy Services Holdings, Inc.

DENNIS JACOBS, Circuit Judge:

2 Andrew L. Wood, a lobbyist with appellee 21st Century Oncology

Associates, Inc. (“21C”) until his termination, appeals from the Decision and

Order of the District Court for the Southern District of New York (McMahon, CJ.)

affirming the judgment of the Bankruptcy Court for the Southern District of New

York (Drain, J.), which reduced Woods’ allowed claim for certain deferred

incentive bonus payments pursuant to section 502(b)(7) of chapter 11 of the U.S.

Code (the “Bankruptcy Code”). That subsection limits claims for damages

“resulting from termination of an employment contract” to the sum of: (1) a

single year of compensation “without acceleration”; and (2) unpaid

compensation “due . . . without acceleration” on the date of termination.

11 U.S.C. § 502(b)(7)(A)-(B).

At the time of termination, certain lobbying objectives specified in Woods’

employment contract had been achieved, triggering provisions that promised

him $10 million in incentive bonuses. Under the contract, the bonus payments

were payable over a period of five years, but became due in full when and

because Woods was fired without cause. On appeal, Woods contends that §

502(b)(7) applies only to forward-looking claims in the nature of severance--not

3 to claims for compensation on account of services already performed--and draws

the analogy to pensions, which courts have declined to cap. Woods argues that

because his rights to receive the incentive bonuses were fully vested prior to his

termination, the timing of the bonus payments was irrelevant to the application

of § 502(b)(7). We affirm because, pursuant to Woods’ contract, portions of the

incentive bonuses were not in fact due prior to termination, but were accelerated

as the contract expressly provides. Accordingly, the plain language of

§ 502(b)(7) requires that we apply its cap to Woods’ claim for accelerated

payments.

BACKGROUND

I

21C, a provider of radiation therapy to cancer patients, employed Woods

from approximately 2010 to September 23, 2016. The Amended and Restated

Executive Employment Agreement dated May 13, 2013 (the “Employment

Agreement”) assigned Woods to promote legislative and administrative

initiatives that would enhance 21C’s profitability by increasing Medicare

4 reimbursements to freestanding radiation therapy clinics. In addition to various

other forms of compensation, including a $1 million annual salary and health

benefits, Woods was promised incentive bonus payments totaling $10 million

(the “Incentive Bonuses”) if the desired reforms were adopted--which they were.

Specifically, Section 3(b) of the Employment Agreement, titled “Executive

Compensation,” provides as follows:

Performance Incentive and Other Bonuses. The Executive shall be entitled to receive the following incentive bonuses:

(i) Five Million Dollars ($5,000,000) from the Company for achievement during the Term of a freeze on reductions in Medicare reimbursement to freestanding radiation therapy centers except for those reductions negotiated on behalf of the Company,

(ii) Two Million Five Hundred Thousand Dollars ($2,500,000) from the Company for achievement during the Term of adoption of a new, multi-bundled payment system for freestanding radiation therapy centers, to which the Company elects not to participate,

(iii) Two Million Five Hundred Thousand Dollars ($2,500,000) upon the Company’s initial election to participate in any way in the system referred to in clause (ii) above, and

(iv) other cash bonuses as agreed to in writing in the future . . . .

Employment Agreement § 3(b).

5 The Incentive Bonuses were payable in annual installments. Woods

would receive the payments over a five-year period of continued employment

except under certain circumstances--including Woods’ termination without

cause--in which case he would receive an “accelerated” lump sum:

Payments under clauses (i) through (iii) above shall be made annually over a five year period, with the first payment payable within five (5) business days following the freeze, adoption or election, respectively. Any deferred payments of incentive bonuses shall be immediately accelerated and paid in full in the event of (A) the Executive’s termination without Cause, termination by the Executive for Good Reason or as a result of the Executive’s death or Disability or (B) upon a “Change of Control” . . . , a “Sale of the Company” . . . , or a “Public Offering” . . . .

Id. (emphasis added). Under the contract, if Woods were terminated without

cause he would receive, in addition to an accelerated Incentive Bonus payment,

24 monthly “Severance Payments” totaling one year’s base salary of $1 million as

well as continued health insurance. Employment Agreement § 5(b).

Conversely, Woods would forfeit any unpaid Incentive Bonuses (as well as the

Severance Payments and health insurance coverage) if he resigned without good

reason or were terminated for cause. See Employment Agreement § 5(d)-(e)

(providing that under these circumstances Woods “shall only be entitled to the

6 Accrued Compensation”); id. §§ 5(b), 6 (distinguishing Accrued Compensation

from “deferred payments of performance incentive bonuses pursuant to Section

3(b)”).

During Woods’ tenure at 21C, the federal government made the changes to

Medicare reimbursement rates and procedures that 21C had sought: on

December 28, 2015, Congress froze reductions in Medicare reimbursement for

freestanding radiation therapy centers like 21C’s; and on June 29, 2016, the

Centers for Medicare and Medicaid Services introduced a multi-bundled

payment system for cancer care services, in which 21C elected to participate. As

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
965 F.3d 196, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-21st-century-oncology-holdings-inc-ca2-2020.